Torsten Hechler

7PUBLICATIONS
42CO-AUTHORS
Molecular targetsPredictive and prognostic markersGlycoconjugatesMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 22, 2026
Physicochemical and Metabolic Optimization of NAMPT Inhibitors Enables Effective Antibody-Drug Conjugates for Liquid and Solid Tumors.

|Mar 17, 2026
Amanitin-Based Fc-Small Molecule-Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy.

Daniela Carraturo, Francesca Gallo, Marisa Schmitt

|Nov 20, 2024
Novel Amanitin-Based Antibody-Drug Conjugates Targeting TROP2 for the Treatment of Pancreatic Cancer.

Eleni Papacharisi, Alexandra C Braun, Marija Vranic

|Oct 23, 2024
ETx-22, a Novel Nectin-4-Directed Antibody-Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4-Expressing Tumors.

Marc Lopez, Emerence Crompot, Emmanuelle Josselin

|Sep 21, 2024
Site-Specific Modification of Native IgGs with Flexible Drug-Load.

Jöri E Wehrmüller, Julia C Frei, Torsten Hechler

|Feb 11, 2021
Targeted immunotherapy for HER2-low breast cancer with 17p loss.

Yujing Li, Yifan Sun, Michael Kulke

Pageof 2

Frequent Collaborators

3 joint publications

Andreas Pahl

2 joint publications

Marija Vranic

1 joint publications

Christian Breunig

1 joint publications

Christoph Müller